Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS
Published February 14, 2024 · Recall initiated: January 19, 2024
Summary
FDA records drug Class II recall D-0288-2024, published February 14, 2024 and initiated January 19, 2024. Recalling firm: OMEZA LLC; Status: Terminated; Reported quantity: 4390 vials; Lot: Lots: 28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- OMEZA LLC
- Distributor
- US Nationwide
- Lot
- Lots: 28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOmeza Skin Protectant, Skin Protectant Gel 10*2mL VialsFebruary 14, 2024
- FDACVS Health brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%), packaged in a) 0.5 FL OZ (15mL)February 14, 2024
- FDALeader brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%), packaged in a) 0.5 FL OZ (15mL) bottlesFebruary 14, 2024
- FDANovoTHOR Whole Body Light Pod, Gen 3.0 (1) Product Code S2188 - Reg (2) Product Code S2189 - Reg PRX (3)February 7, 2024
- FDAAtlan, Gas Machine for Anesthesia or Analgesia, Catalog numbers 8621500 (Atlan A350) and 8621600 (Atlan A350February 7, 2024
- FDAVortex Surgical ACTU8 FORCEPS, 25 GA, ADAPTIVE, REF VS0740.25February 7, 2024
Questions about this recall
Was Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS recalled?
Yes. FDA published recall D-0288-2024 on February 14, 2024. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail